AIxCrypto Holdings (AIXC)
Nasdaq Market Open
AIxCrypto Holdings, Inc. is a technology infrastructure company operating at the intersection of artificial intelligence, blockchain, and programmable digital systems. Its common stock trades under the symbol AIXC, and the company positions itself around the development of software platforms that can connect traditional financial assets, on-chain networks, and AI-enabled commercial applications.
The company’s strategy centres on two emerging technology themes: tokenisation of real-world assets and embodied artificial intelligence. Real-world asset tokenisation refers to the process of representing assets such as securities, commodities, property interests, or other financial rights on blockchain-based systems. This can potentially make ownership records, transfers, compliance workflows, and settlement processes more programmable, although adoption depends heavily on regulation, market infrastructure, and institutional trust.
AIxCrypto also focuses on embodied artificial intelligence, a term commonly used for AI systems deployed in physical or commercial environments rather than only in software interfaces. In a business context, this may include AI-driven systems that interact with operational processes, machines, sensors, or customer-facing infrastructure. The company aims to build programmable infrastructure that can support these use cases while maintaining links to regulated markets and enterprise requirements.
What distinguishes AIxCrypto is its attempt to combine blockchain-based automation with AI deployment frameworks. Instead of presenting itself solely as a cryptocurrency or AI software vendor, it describes its role as an infrastructure layer for commercial systems that need verifiable records, programmable transactions, and intelligent automation. The company is therefore exposed to investor interest in digital assets, fintech modernisation, and applied AI, while also facing the execution and regulatory risks typical of early-stage technology platforms.
Last updated
- Market Cap
- 25.5M
- P/E
- —
- P/FCF
- —
- P/S
- —
- Enterprise Value
- 19.29M
- Sector
- —
- Industry
- —
- Address
- 1990 E. GRAND AVENUE, EL SEGUNDO, CA, 90245
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Completes its “Dual Flywheel, Dual Bridge, and Dual Listed-Company” Structure; First batch of FX Super One Complete Sets of Components to Arrive at Port of Long Beach Next Week
Faraday Future Completes Formation of “FFAI+AIXC” Dual-Flywheel, Dual-Bridge, and Dual-Listed Company System; Its Majority Owned Crypto Company Renamed as AIxCrypto (Nasdaq: AIXC)
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 25.5M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 19.29M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.17
- P/S
P/S ratio compares a company's share price to its revenue per share.
- —
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -1.3
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- —
- EPS
- -1.13
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -104.98%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -96.07%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 11.57
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 11.57
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 3.05
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 44.87K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 1.26
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -4.52M | -7.36M | -1.43M | -1.68M | -2.72M |
| EBITDA | -4.33M | -7.36M | -1.43M | -1.68M | -2.72M |
| Net income | -6.08M | -12.29M | -2.91M | -1.69M | -2.65M |
| Basic EPS | -0.79 | -3.76 | -4.68 | -1 | -1.82 |
| Diluted EPS | -0.79 | -3.76 | -4.68 | -1 | -1.82 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 23.9M | 31.28M | 43.47M | 3.96M | 2.85M |
| Total liabilities | 2.03M | 3.33M | 4.92M | 5.61M | 2.81M |
| Total equity | 21.87M | 27.95M | 38.55M | -1.65M | 33.13K |
| Cash & equivalents | 6.2M | 19.33M | 38.78M | 331.6K | 30.21K |
| Current assets | 23.49M | 30.95M | 43.47M | 3.96M | 2.85M |
| Current liabilities | 2.03M | 3.33M | 4.92M | 5.61M | 2.81M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -4.5M | -2.12M | -2.14M | -1.1M | -1.59M |
| Investing cash flow | -8.5M | -14.07M | -291K | -1.21M | -305K |
| Financing cash flow | -132K | -3.25M | 40.88M | 2.61M | 750K |
| Change in cash | -13.13M | -19.44M | 38.45M | 301.39K | -1.14M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | S-8 — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-K — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | EFFECT — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | CORRESP — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | DEL AM — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | 3 — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | 3 — AIxCrypto Holdings, Inc. | View Filing | |
| form 3 | Form 3 — Wang Jiawei | View Filing | |
| form 3 | Form 3 — Wang Jiawei | View Filing | |
| form 3 | Form 3 — FARADAY FUTURE INTELLIGENT ELECTRIC INC. | View Filing | |
| form 3 | Form 3 — FARADAY FUTURE INTELLIGENT ELECTRIC INC. | View Filing | |
| edgar index | S-1 — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | 8-K — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | SCHEDULE 13D/A — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 10-Q — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | SCHEDULE 13D — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | DEF 14A — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | PRE 14A — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | EFFECT — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | RW — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | UPLOAD — AIxCrypto Holdings, Inc. | View Filing | |
| edgar index | CORRESP — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | S-1 — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 10-Q — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | D — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 10-Q — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 10-K — Qualigen Therapeutics, Inc. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | NT 10-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | 8-K — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | EFFECT — Qualigen Therapeutics, Inc. | View Filing | |
| edgar index | UPLOAD — Qualigen Therapeutics, Inc. | View Filing |